Received Jun 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | N/A | 3032233 | IM / RA |
Passed away
DEPRESSION, UNSPECIFIED(F32.A), PAIN, UNSPECIFIED(R52), UNSPECIFIED DEMENTIA, SEVERE, WITH AGITATION(F03.C11), ENCOUNTER FOR PROPHYLACTIC MEASURES, UNSPECIFIED(Z29.9), ATRIOVENTRICULAR BLOCK, FIRST DEGREE(I44.0), CONSTIPATION, UNSPECIFIED(K59.00), VITAMIN D DEFICIENCY, UNSPECIFIED(E55.9), OTHER SPECIFIED PERSONAL RISK FACTORS, NOT ELSEWHERE CLASSIFIED(Z91.89), BILATERAL PRIMARY OSTEOARTHRITIS OF KNEE(M17.0), LOCALIZED EDEMA(R60.0), PRIMARY OSTEOARTHRITIS, LEFT HAND(M19.042), PATIENT'S OTHER NONCOMPLIANCE WITH MEDICATION REGIMEN(Z91.14), BENIGN PROSTATIC HYPERPLASIA WITH LOWER URINARY TRACT SYMPTOMS(N40.1), CHRONIC PEPTIC ULCER, SITE UNSPECIFIED, WITHOUT HEMORRHAGE OR PERFORATION(K27.7), ANESTHESIA OF SKIN(R20.0), ABNORMAL LEVELS OF OTHER SERUM ENZYMES(R74.8), HYPERCALCEMIA(E83.52), PURE HYPERCHOLESTEROLEMIA, UNSPECIFIED(E78.00), UNSPECIFIED HEARING LOSS, BILATERAL(H91.93), REPEATED FALLS(R29.6), NONALCOHOLIC STEATOHEPATITIS (NASH)(K75.81), ESSENTIAL (PRIMARY) HYPERTENSION(I10), TYPE 2 DIABETES MELLITUS WITHOUT COMPLICATIONS(E11.9), HEART FAILURE, UNSPECIFIED(I50.9), CARDIAC MURMUR, UNSPECIFIED(R01.1), UNSPECIFIED RIGHT BUNDLE-BRANCH BLOCK(I45.10), PAROXYSMAL ATRIAL FIBRILLATION(I48.0), UNSPECIFIED DEMENTIA, UNSPECIFIED SEVERITY, WITHOUT BEHAVIORAL DISTURBANCE, PSYCHOTIC DISTURBANCE, MOOD DISTURBANCE, AND ANXIETY (F03.90)
acetaminophen, ayr saline gel nasal, calcitonin nasal solution, carvedilol, eliquis, fluoxetine, furosemide, gabapentin, metformin, mineral oil, miralax, potassium cl, tamsulosin, tramadol, trazodone, vicks vabo rub, vitamin d3